Navigation Links
Doctor-aided suicide: No slippery slope
Date:9/26/2007

Contrary to arguments by critics, a University of Utah-led study found that legalizing physician-assisted suicide in Oregon and the Netherlands did not result in a disproportionate number of deaths among the elderly, poor, women, minorities, uninsured, minors, chronically ill, less educated or psychiatric patients.

Of 10 vulnerable groups examined in the study, only AIDS patients used doctor-assisted suicide at elevated rates.

Fears about the impact on vulnerable people have dominated debate about physician-assisted suicide. We find no evidence to support those fears where this practice already is legal, says the studys lead author, bioethicist Margaret Battin, a University of Utah distinguished professor of philosophy and adjunct professor of internal medicine.

The study will be published in the October 2007 issue of the Journal of Medical Ethics. Battin conducted the research with public health physician Agnes van der Heide, of Erasmus Medical Center, Rotterdam; psychiatrist Linda Ganzini at Oregon Health & Science University, Portland; and physician Gerrit van der Wal and health scientist Bregje Onwuteaka-Philipsen, of the VU University Medical Center, Amsterdam. Van der Wal currently is inspector general of The Netherlands Health Care Inspectorate, which advises that nations health minister.

The research deals with the so-called slippery slope argument that has been made by critics of doctor-assisted suicide and has raised concern even among proponents. The argument is that by making it legal for medical doctors to help certain patients end their lives, vulnerable people will die in disproportionately large numbers.

Would these patients be pressured, manipulated or forced to request or accept physician-assisted dying by overburdened family members, callous physicians, or institutions or insurers concerned about their own profits" the researchers asked.

The American College of Physicians said in
'/>"/>

Contact: Lee Siegel
leesiegel@ucomm.utah.edu
801-581-8993
University of Utah
Source:Eurekalert

Page: 1 2 3 4

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/15/2008)...ural organic atoms with metal complexes, scientist...e of enzyme inhibitor capable of blocking a bioche...lopment. , Based on studies in human melanoma c...w ways to treat cancer by dampening the overactive...growth. , Details of the study, to be published ...
(Date:5/15/2008)...audit of community hospitals associated with Fox C... partnership between a major academic cancer cente... and community hospitals, where most care is provi...ffectively disseminating advances in cancer treatm...ive Cancer Center in Philadelphia, first establish...
(Date:5/15/2008)...he anti-inflammatory medication also known by the ...uces a specific proliferation measurement of preca...from The University of Texas M. D. Anderson Cancer...e of COX-2 inhibition toward preventing lung cance...disease. , The study is the first large randomiz...
(Date:5/15/2008)...re/ -- JumpStart Inc., the Northeast Ohio,venture ...th of innovative,early-stage businesses and ideas,...0 in CerviLenz(TM), Inc. The Cleveland-based compa...inistration cleared medical,device that allows obs...egnant women, which has been established by the Na...
Breaking Medicine News(10 mins):Health News:Novel enzyme inhibitor paves way for new cancer drug 2Health News:Novel enzyme inhibitor paves way for new cancer drug 3Health News:Partnership of academic centers and community hospitals effective model for disseminating advances 2Health News:Partnership of academic centers and community hospitals effective model for disseminating advances 3Health News:Celebrex shows benefit in first-of-its-kind lung cancer chemoprevention trial 2Health News:Celebrex shows benefit in first-of-its-kind lung cancer chemoprevention trial 3Health News:CerviLenz Receives JumpStart Investment 2Health News:CerviLenz Receives JumpStart Investment 3
...search and Development (R&D) is slated to become t...in India with a growing number of multinational ph...perations in the country. According to the intern...ting firm Boston Consulting Group, India would soo...
...Indian and foreign scientists has claimed to have ...ied on for many generations in families in the cou...orders of Guru Nanak Dev University here in associ...al Institute of Health, USA and the Institute of H...
... though it is of common sense that treatment shoul...tely is not common practice especially among patie...dies conducted by the International Osteoporosis F...rescribed therapy is a ‘worldwide problem of strik...
...ernment will come up with a bill seeking direct co...d diagnostic centres in the state, State Health Mi...nning to introduce a special bill in the next asse...th centres operating in the state. This is to chec...
Other Medicine News:Health News:Campaign To Create Awareness For Following A stricter Drug Regime For Osteoporosis 2Health News:Campaign To Create Awareness For Following A stricter Drug Regime For Osteoporosis 3
(Date:5/15/2008)...SAN FRANCISCO, May 15 /- Me...at data from an ongoing Phase 1-2 clinical,trial o... will be presented,in an oral presentation at the ...Annual Meeting in Chicago., Session title: New ...cer Session date and time: Monday, June 2 at 11:3...
(Date:5/15/2008)...ase II Data Presented at ASCO Showed Acceptable To... of Grade 3 and 4 Neuropathy, WOODCLIFF LAKE, N.J...otherapeutic agent eribulin mesylate (E7389) demon...n of women with locally advanced or metastatic,bre... Phase II clinical,trial. The study also suggests ...
(Date:5/15/2008)...KENILWORTH, N.J., May 15 /-...er in advancing the science and treatment of,chron...day that data from,several clinical studies with P...) (ribavirin, USP) combination therapy, as well as...V protease inhibitor, will be presented at,the 39t...
(Date:5/15/2008)...xcellent results obtained with a newly cleared dev...plaques of interest that are associated with ...BURLINGTON, Mass., May 15 /- InfraReD...t Hospital in Royal Oak, Mich., have,successfully ... patient,undergoing a cardiac catheterization. Thi...
Breaking Medicine Technology:Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 2Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 3Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 2Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 3Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 2Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 3Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 4Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 5Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 6Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 7First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 2First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 3First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 4Transportation 3A Making Connections Event to Explore Opportunities and Solutions for People With Disabilities 18695 1Transportation 3A Making Connections Event to Explore Opportunities and Solutions for People With Disabilities 18695 2Fitness and Figure Professionals Adela Garcia and Sonia Adcock to Represent GNC at Contra Costa Championship 18692 1Fitness and Figure Professionals Adela Garcia and Sonia Adcock to Represent GNC at Contra Costa Championship 18692 2Vail Valley Medical Center Board of Directors Announces Appointment of New President 26 CEO John Cassin 18689 1Vail Valley Medical Center Board of Directors Announces Appointment of New President 26 CEO John Cassin 18689 2Electronic Pillbox Helps Seniors Stick to Drug Regimens 18686 1Electronic Pillbox Helps Seniors Stick to Drug Regimens 18686 2Electronic Pillbox Helps Seniors Stick to Drug Regimens 18686 3
...ed 11 Percent Fewer RA Patients,Reported Job Loss ...red to Methotrexate Alone, BARCELONA, Spain, June ...ritis (RA) is one of the most common causes of,dis...day show that,rheumatoid arthritis (RA) patients t... working longer, had fewer absences and reported,g...
...007 /PRNewswire-FirstCall/ --,Genzyme Corp. today ... a powder form of Renvela (sevelamer carbonate) to...ing one trial in which,patients received the powde...s administered once per day. , Genzyme is developi... option for patients with chronic kidney disease i...
Other Medicine Technology:Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 2Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 3Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 4Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 5Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 6Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 7Genzyme Announces Results of Clinical Trials Investigating Powder,Form of Sevelamer Carbonate 2Genzyme Announces Results of Clinical Trials Investigating Powder,Form of Sevelamer Carbonate 3Genzyme Announces Results of Clinical Trials Investigating Powder,Form of Sevelamer Carbonate 4Genzyme Announces Results of Clinical Trials Investigating Powder,Form of Sevelamer Carbonate 5
Disposable bars made of silver/silver chloride have contacts spaced three centimeters center-tocenter. Also perforated for easy separation into two individual tabs. For use with mini-crocodile clip l
Our SurgiCool surgeon cooling system has been developed utilizing all the expertise gained in high performance motorsports. Our cool suit is simple to use and provides powerful cooling from ice water
Wrap-around, silver/silver chloride ring electrodes fit pediatric to adult patients. For use with minicrocodile clip lead wires (page 17). Dimensions: 10 cm (4 in) long, 0.6 cm (0.25 in) wide. Each 1
... Precision PCx point of care blood glucose monitor...system for healthcare professionals. Ergonomic and...esults. Automatic upload of results to hospital an...data management capabilities.,The Precision P...
Medicine Products: